Reconciliation of Net Tax Provision |
The net tax provision differs from that expected by applying the combined federal and provincial tax rates of 27.0% (March 31, 2024 – 27.0%) to income (loss) before income tax for the following items: | | | | | | | | | | March 31, 2025 | March 31, 2024 | | $ | $ | Income (loss before tax) | 20,382 | | (57,637) | | Combined federal and provincial rate | 27.0 | % | 27.0 | % | Expected tax expense (recovery) | 5,503 | | (15,562) | | | | | | | | Non-deductible expenses (recovery) | 3,070 | | 3,519 | | Non-deductible (non-taxable) portion of capital items | (3,620) | | (2,441) | | | | | Goodwill and other impairment items | — | | 1,674 | | Tax impact on divestitures | — | | 953 | | Difference in statutory tax rate | 2,400 | | 1,031 | | Effect of change in tax rates | (1,530) | | (5,277) | | Changes in deferred tax benefits not recognized | (5,777) | | 15,549 | | Change in tax legislation | 4,573 | | — | | Income tax expense (recovery) | 4,619 | | (554) | |
|
Deferred Tax Assets (Liabilities) and Temporary Differences |
Movements in deferred tax assets (liabilities) at March 31, 2025 and March 31, 2024 are comprised of the following: | | | | | | | | | | | | | | | | | | Balance, March 31, 2024 | | Recovered through (charged to) earnings | Recovered through (charged to) other comprehensive income | | Balance, March 31, 2025 | | $ | | $ | $ | | $ | Deferred tax assets | | | | | | | Non-capital losses | 23,740 | | | 4,293 | | 243 | | | 28,276 | | Capital losses | 56 | | | 271 | | — | | | 327 | | Finance costs | 64 | | | 500 | | — | | | 564 | | | | | | | | | | | | | | | | | | | | | | | Leases | 6,238 | | | (989) | | 96 | | | 5,345 | | Others | (109) | | | 147 | | 22 | | | 60 | | Total deferred tax assets | 29,989 | | | 4,222 | | 361 | | | 34,572 | | | | | | | | | Deferred tax liabilities | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | | Intangible assets | (7,742) | | | (497) | | (402) | | | (8,641) | | Property, plant and equipment | (12,380) | | | (6,206) | | 52 | | | (18,534) | | Inventory | (5,709) | | | 603 | | (32) | | | (5,138) | | Biological assets | (4,863) | | | 5,640 | | — | | | 777 | | Others | (142) | | | (573) | | 1 | | | (714) | | Total deferred tax liabilities | (30,836) | | | (1,033) | | (381) | | | (32,250) | | | | | | | | | Net deferred tax assets (liabilities) | (847) | | | 3,189 | | (20) | | | 2,322 | |
| | | | | | | | | | | | | | | | | | | | Balance, March 31, 2023 | | Recovered through (charged to) earnings | Recovered through (charged to) other comprehensive income | Recovered through (charged to) equity | Balance, March 31, 2024 | | $ | | $ | $ | $ | $ | Deferred tax assets | | | | | | | Non-capital losses | 31,903 | | | (6,842) | | (43) | | (1,278) | | 23,740 | | Capital losses | 142 | | | (86) | | — | | — | | 56 | | Finance costs | 118 | | | (54) | | — | | — | | 64 | | Investment tax credit | 1,282 | | | (1,282) | | — | | — | | — | | | | | | | | | Derivatives | 26 | | | (26) | | — | | — | | — | | Leases | 6,529 | | | (287) | | (4) | | — | | 6,238 | | Others | 1 | | | (122) | | 12 | | — | | (109) | | Total deferred tax assets | 40,001 | | | (8,699) | | (35) | | (1,278) | | 29,989 | | | | | | | | | Deferred tax liabilities | | | | | | | Convertible debenture | (3,402) | | | 3,402 | | — | | — | | — | | Investment in associates | (12) | | | 12 | | — | | — | | — | | | | | | | | | Intangible assets | (12,624) | | | 4,826 | | 56 | | — | | (7,742) | | Property, plant and equipment | (16,265) | | | 3,893 | | (8) | | — | | (12,380) | | Inventory | (5,218) | | | (491) | | — | | — | | (5,709) | | Biological assets | (2,070) | | | (2,793) | | — | | — | | (4,863) | | Others | (1,655) | | | 1,513 | | — | | — | | (142) | | Total deferred tax liabilities | (41,246) | | | 10,362 | | 48 | | — | | (30,836) | | | | | | | | | Net deferred tax liabilities | (1,245) | | | 1,663 | | 13 | | (1,278) | | (847) | |
Deferred tax assets (liabilities) as presented in the consolidated statements of financial position:
| | | | | | | | | | March 31, 2025 | March 31, 2024 | | $ | $ | Deferred tax assets | 4,219 | | 15,343 | | Deferred tax liabilities | (1,897) | | (16,190) | | Net deferred tax assets (liabilities) | 2,322 | | (847) | |
Deferred tax assets have not been recognized with respect to the following deductible temporary differences: | | | | | | | | | | March 31, 2025 | March 31, 2024 | | $ | $ | Non-capital losses carried forward | 1,293,859 | | 1,359,623 | | | | | Capital losses | 182,749 | | 203,843 | | Property, plant and equipment | 579,392 | | 555,376 | | Intangible assets | 71,559 | | 74,068 | | Goodwill | 29,021 | | 29,936 | | Marketable securities | 23,224 | | 22,210 | | Investment tax credits | 6,696 | | 6,696 | | Derivatives | 4,393 | | 11,254 | | Capital lease obligations | 21,269 | | 17,250 | | Other | 18,004 | | 29,143 | | | 2,230,166 | | 2,309,399 | |
The Company has income tax loss carryforwards of approximately $1,254.9 million (March 31, 2024 – $1,251.2 million) which are predominately from Canada and if unused, will expire as follows:
| | | | | | | | | Expiration year | | | | $ | 2026 | 2030 | 142,715 | | 2031 | 2035 | 225,324 | | 2036 | 2040 | 505,870 | | 2041 | 2045 | 381,021 | | | | 1,254,930 | |
|